The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--Over 22 years.

Susan Jacups, Allen Cheng

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Background: Diseases caused by Streptococcus pneumoniae continue to cause substantial morbidity and mortality throughout the world. Furthermore, detrimental outcomes are more pronounced in some populations-such as those living in third world poverty, and Indigenous people who live in developed nations.

    Methods: This study describes the epidemiology of blood culture positive S. pneumoniae community-acquired pneumonia (CAP) in the Top End of the Northern Territory of Australia. Demographics, indigenous status, medical risk factors, serotype and outcomes were collected from adults presenting to hospital with blood culture positive S. pneumoniae CAP, from 1987 to 2008.

    Results: We report 205 cases, with a median age of 40 years. The average overall incidence rate ratio was 10.3 for indigenous adults compared with non-indigenous adults. There was no statistical difference between incidence rates pre and post-23-valent pneumococcal polysaccharide vaccine (23vPPV) introduction. Serotypes in presenting cases were predominantly (84.7%) 23vPPV types. The whole-population logistic regression model identified significant adjusted relative risks: 95% CI, for age 45 and older 1.6: 1.1, 2.2, indigenous 5.9: 3.7, 9.5, diabetes 2.3: 1.6, 3.3, excess alcohol 4.8: 2.8, 8.3, smoking 2.7: 1.9, 3.7 with indigenous. +. excess alcohol 18.5: 17.3, 19.7 as predictive for bacteremic S. pneumoniae CAP presentation.

    Conclusions: Our results suggest that, the national 23vPPV program appears to be under-utilized. An integrated Public Health approach vigorously targeting indigenous adolescents, before substances such as alcohol and smoking are habitual, together with increased vaccine coverage, will reduce the burden of pneumococcal disease in this population. � 2011.
    Original languageEnglish
    Pages (from-to)5386-5392
    Number of pages7
    JournalVaccine
    Volume29
    Issue number33
    DOIs
    Publication statusPublished - 26 Jul 2011

    Fingerprint

    Northern Territory
    Streptococcus pneumoniae
    Pneumococcal Vaccines
    pneumonia
    epidemiology
    Pneumonia
    Epidemiology
    vaccines
    polysaccharides
    alcohols
    Alcohols
    serotypes
    Logistic Models
    Smoking
    Population
    incidence
    burden of disease
    indigenous peoples
    Incidence
    blood

    Cite this

    @article{c3df1882c7c944dd93bcbbe720f14aa1,
    title = "The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--Over 22 years.",
    abstract = "Background: Diseases caused by Streptococcus pneumoniae continue to cause substantial morbidity and mortality throughout the world. Furthermore, detrimental outcomes are more pronounced in some populations-such as those living in third world poverty, and Indigenous people who live in developed nations. Methods: This study describes the epidemiology of blood culture positive S. pneumoniae community-acquired pneumonia (CAP) in the Top End of the Northern Territory of Australia. Demographics, indigenous status, medical risk factors, serotype and outcomes were collected from adults presenting to hospital with blood culture positive S. pneumoniae CAP, from 1987 to 2008. Results: We report 205 cases, with a median age of 40 years. The average overall incidence rate ratio was 10.3 for indigenous adults compared with non-indigenous adults. There was no statistical difference between incidence rates pre and post-23-valent pneumococcal polysaccharide vaccine (23vPPV) introduction. Serotypes in presenting cases were predominantly (84.7{\%}) 23vPPV types. The whole-population logistic regression model identified significant adjusted relative risks: 95{\%} CI, for age 45 and older 1.6: 1.1, 2.2, indigenous 5.9: 3.7, 9.5, diabetes 2.3: 1.6, 3.3, excess alcohol 4.8: 2.8, 8.3, smoking 2.7: 1.9, 3.7 with indigenous. +. excess alcohol 18.5: 17.3, 19.7 as predictive for bacteremic S. pneumoniae CAP presentation. Conclusions: Our results suggest that, the national 23vPPV program appears to be under-utilized. An integrated Public Health approach vigorously targeting indigenous adolescents, before substances such as alcohol and smoking are habitual, together with increased vaccine coverage, will reduce the burden of pneumococcal disease in this population. � 2011.",
    keywords = "Pneumococcus vaccine, adolescent, adult, alcohol consumption, article, Australia, blood culture, cigarette smoking, community acquired pneumonia, controlled study, diabetes mellitus, female, human, indigenous people, major clinical study, male, morbidity, mortality, priority journal, risk factor, serotype, Streptococcus pneumoniae, Adolescent, Adult, Aged, Aged, 80 and over, Bacteremia, Blood, Community-Acquired Infections, Female, Humans, Male, Middle Aged, Northern Territory, Pneumococcal Vaccines, Pneumonia, Pneumococcal, Risk Factors, Serotyping, Treatment Outcome, Vaccination, Young Adult",
    author = "Susan Jacups and Allen Cheng",
    year = "2011",
    month = "7",
    day = "26",
    doi = "10.1016/j.vaccine.2011.05.082",
    language = "English",
    volume = "29",
    pages = "5386--5392",
    journal = "Vaccine",
    issn = "0264-410X",
    publisher = "Elsevier",
    number = "33",

    }

    The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--Over 22 years. / Jacups, Susan; Cheng, Allen.

    In: Vaccine, Vol. 29, No. 33, 26.07.2011, p. 5386-5392.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--Over 22 years.

    AU - Jacups, Susan

    AU - Cheng, Allen

    PY - 2011/7/26

    Y1 - 2011/7/26

    N2 - Background: Diseases caused by Streptococcus pneumoniae continue to cause substantial morbidity and mortality throughout the world. Furthermore, detrimental outcomes are more pronounced in some populations-such as those living in third world poverty, and Indigenous people who live in developed nations. Methods: This study describes the epidemiology of blood culture positive S. pneumoniae community-acquired pneumonia (CAP) in the Top End of the Northern Territory of Australia. Demographics, indigenous status, medical risk factors, serotype and outcomes were collected from adults presenting to hospital with blood culture positive S. pneumoniae CAP, from 1987 to 2008. Results: We report 205 cases, with a median age of 40 years. The average overall incidence rate ratio was 10.3 for indigenous adults compared with non-indigenous adults. There was no statistical difference between incidence rates pre and post-23-valent pneumococcal polysaccharide vaccine (23vPPV) introduction. Serotypes in presenting cases were predominantly (84.7%) 23vPPV types. The whole-population logistic regression model identified significant adjusted relative risks: 95% CI, for age 45 and older 1.6: 1.1, 2.2, indigenous 5.9: 3.7, 9.5, diabetes 2.3: 1.6, 3.3, excess alcohol 4.8: 2.8, 8.3, smoking 2.7: 1.9, 3.7 with indigenous. +. excess alcohol 18.5: 17.3, 19.7 as predictive for bacteremic S. pneumoniae CAP presentation. Conclusions: Our results suggest that, the national 23vPPV program appears to be under-utilized. An integrated Public Health approach vigorously targeting indigenous adolescents, before substances such as alcohol and smoking are habitual, together with increased vaccine coverage, will reduce the burden of pneumococcal disease in this population. � 2011.

    AB - Background: Diseases caused by Streptococcus pneumoniae continue to cause substantial morbidity and mortality throughout the world. Furthermore, detrimental outcomes are more pronounced in some populations-such as those living in third world poverty, and Indigenous people who live in developed nations. Methods: This study describes the epidemiology of blood culture positive S. pneumoniae community-acquired pneumonia (CAP) in the Top End of the Northern Territory of Australia. Demographics, indigenous status, medical risk factors, serotype and outcomes were collected from adults presenting to hospital with blood culture positive S. pneumoniae CAP, from 1987 to 2008. Results: We report 205 cases, with a median age of 40 years. The average overall incidence rate ratio was 10.3 for indigenous adults compared with non-indigenous adults. There was no statistical difference between incidence rates pre and post-23-valent pneumococcal polysaccharide vaccine (23vPPV) introduction. Serotypes in presenting cases were predominantly (84.7%) 23vPPV types. The whole-population logistic regression model identified significant adjusted relative risks: 95% CI, for age 45 and older 1.6: 1.1, 2.2, indigenous 5.9: 3.7, 9.5, diabetes 2.3: 1.6, 3.3, excess alcohol 4.8: 2.8, 8.3, smoking 2.7: 1.9, 3.7 with indigenous. +. excess alcohol 18.5: 17.3, 19.7 as predictive for bacteremic S. pneumoniae CAP presentation. Conclusions: Our results suggest that, the national 23vPPV program appears to be under-utilized. An integrated Public Health approach vigorously targeting indigenous adolescents, before substances such as alcohol and smoking are habitual, together with increased vaccine coverage, will reduce the burden of pneumococcal disease in this population. � 2011.

    KW - Pneumococcus vaccine

    KW - adolescent

    KW - adult

    KW - alcohol consumption

    KW - article

    KW - Australia

    KW - blood culture

    KW - cigarette smoking

    KW - community acquired pneumonia

    KW - controlled study

    KW - diabetes mellitus

    KW - female

    KW - human

    KW - indigenous people

    KW - major clinical study

    KW - male

    KW - morbidity

    KW - mortality

    KW - priority journal

    KW - risk factor

    KW - serotype

    KW - Streptococcus pneumoniae

    KW - Adolescent

    KW - Adult

    KW - Aged

    KW - Aged, 80 and over

    KW - Bacteremia

    KW - Blood

    KW - Community-Acquired Infections

    KW - Female

    KW - Humans

    KW - Male

    KW - Middle Aged

    KW - Northern Territory

    KW - Pneumococcal Vaccines

    KW - Pneumonia, Pneumococcal

    KW - Risk Factors

    KW - Serotyping

    KW - Treatment Outcome

    KW - Vaccination

    KW - Young Adult

    UR - http://www.scopus.com/inward/record.url?scp=79960381830&partnerID=8YFLogxK

    U2 - 10.1016/j.vaccine.2011.05.082

    DO - 10.1016/j.vaccine.2011.05.082

    M3 - Article

    VL - 29

    SP - 5386

    EP - 5392

    JO - Vaccine

    JF - Vaccine

    SN - 0264-410X

    IS - 33

    ER -